Literature DB >> 19433858

Thymic output, T-cell diversity, and T-cell function in long-term human SCID chimeras.

Marcella Sarzotti-Kelsoe1, Chan M Win, Roberta E Parrott, Myriah Cooney, Barry K Moser, Joseph L Roberts, Gregory D Sempowski, Rebecca H Buckley.   

Abstract

Severe combined immunodeficiency (SCID) is a syndrome of diverse genetic cause characterized by profound deficiencies of T, B, and sometimes NK-cell function. Nonablative human leukocyte antigen-identical or rigorously T cell-depleted haploidentical parental bone marrow transplantation (BMT) results in thymus-dependent genetically donor T-cell development in the recipients, leading to long-term survival. We reported previously that normal T-cell numbers, function, and repertoire developed by 3 to 4 months after transplantation in SCID patients, and the repertoire remained highly diverse for the first 10 years after BMT. The T-cell receptor diversity positively correlated with T-cell receptor excision circle levels, a reflection of thymic output. However, the fate of thymic function in SCID patients beyond 10 to 12 years after BMT remained to be determined. In this greater than 25-year follow-up study of 128 patients with 11 different molecular types of SCID after nonconditioned BMT, we provide evidence that T-cell function, thymic output, and T-cell clonal diversity are maintained long-term.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19433858      PMCID: PMC2727406          DOI: 10.1182/blood-2009-01-199323

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  29 in total

1.  Regulation of thymus size by competition for stromal niches among early T cell progenitors.

Authors:  Susan E Prockop; Howard T Petrie
Journal:  J Immunol       Date:  2004-08-01       Impact factor: 5.422

2.  Detection of Y chromosome by in situ hybridization in combination with membrane antigens by two-color immunofluorescence.

Authors:  H van den Berg; J M Vossen; R Langlois van den Bergh; J Bayer; M J van Tol
Journal:  Lab Invest       Date:  1991-05       Impact factor: 5.662

3.  T cell repertoire development in humans with SCID after nonablative allogeneic marrow transplantation.

Authors:  Marcella Sarzotti; Dhavalkumar D Patel; Xiaojing Li; Daniel A Ozaki; Shui Cao; Scott Langdon; Roberta E Parrott; Katherine Coyne; Rebecca H Buckley
Journal:  J Immunol       Date:  2003-03-01       Impact factor: 5.422

4.  Development of immunity in human severe primary T cell deficiency following haploidentical bone marrow stem cell transplantation.

Authors:  R H Buckley; S E Schiff; H A Sampson; R I Schiff; M L Markert; A P Knutsen; M S Hershfield; A T Huang; G H Mickey; F E Ward
Journal:  J Immunol       Date:  1986-04-01       Impact factor: 5.422

5.  Interleukin-2 receptor gamma chain mutation results in X-linked severe combined immunodeficiency in humans.

Authors:  M Noguchi; H Yi; H M Rosenblatt; A H Filipovich; S Adelstein; W S Modi; O W McBride; W J Leonard
Journal:  Cell       Date:  1993-04-09       Impact factor: 41.582

Review 6.  T-cell repertoire diversity and clonal expansions in normal and clinical samples.

Authors:  C Pannetier; J Even; P Kourilsky
Journal:  Immunol Today       Date:  1995-04

7.  Lymphocyte subsets in healthy children from birth through 18 years of age: the Pediatric AIDS Clinical Trials Group P1009 study.

Authors:  William T Shearer; Howard M Rosenblatt; Rebecca S Gelman; Rebecca Oyomopito; Susan Plaeger; E Richard Stiehm; Diane W Wara; Steven D Douglas; Katherine Luzuriaga; Elizabeth J McFarland; Ram Yogev; Mobeen H Rathore; Wende Levy; Bobbie L Graham; Stephen A Spector
Journal:  J Allergy Clin Immunol       Date:  2003-11       Impact factor: 10.793

8.  Janus kinase 3 (JAK3) deficiency: clinical, immunologic, and molecular analyses of 10 patients and outcomes of stem cell transplantation.

Authors:  Joseph L Roberts; Andrea Lengi; Stephanie M Brown; Min Chen; Yong-Jie Zhou; John J O'Shea; Rebecca H Buckley
Journal:  Blood       Date:  2003-11-13       Impact factor: 22.113

9.  Immunologic studies of aging. V. Impaired proliferation of PHA responsive human lymphocytes in culture.

Authors:  J M Hefton; G J Darlington; B A Casazza; M E Weksler
Journal:  J Immunol       Date:  1980-09       Impact factor: 5.422

Review 10.  Molecular defects in human severe combined immunodeficiency and approaches to immune reconstitution.

Authors:  Rebecca H Buckley
Journal:  Annu Rev Immunol       Date:  2004       Impact factor: 28.527

View more
  35 in total

Review 1.  Transplantation immunology: solid organ and bone marrow.

Authors:  Javier Chinen; Rebecca H Buckley
Journal:  J Allergy Clin Immunol       Date:  2010-02       Impact factor: 10.793

2.  Early vs. delayed diagnosis of severe combined immunodeficiency: a family perspective survey.

Authors:  Alice Chan; Christopher Scalchunes; Marcia Boyle; Jennifer M Puck
Journal:  Clin Immunol       Date:  2010-10-28       Impact factor: 3.969

3.  A Markov model to analyze cost-effectiveness of screening for severe combined immunodeficiency (SCID).

Authors:  Kee Chan; Joie Davis; Sung-Yun Pai; Francisco A Bonilla; Jennifer M Puck; Michael Apkon
Journal:  Mol Genet Metab       Date:  2011-07-12       Impact factor: 4.797

4.  T cell and B Cell immunity can be reconstituted with mismatched hematopoietic stem cell transplantation without alkylator therapy in artemis-deficient mice using anti-natural killer cell antibody and photochemically treated sensitized donor T cells.

Authors:  Tony Z Xiao; Kanal Singh; Elizabeth Dunn; Rageshree Ramachandran; Morton J Cowan
Journal:  Biol Blood Marrow Transplant       Date:  2011-10-19       Impact factor: 5.742

Review 5.  Current Knowledge and Priorities for Future Research in Late Effects after Hematopoietic Stem Cell Transplantation (HCT) for Severe Combined Immunodeficiency Patients: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric HCT.

Authors:  Jennifer Heimall; Jennifer Puck; Rebecca Buckley; Thomas A Fleisher; Andrew R Gennery; Benedicte Neven; Mary Slatter; Elie Haddad; Luigi D Notarangelo; K Scott Baker; Andrew C Dietz; Christine Duncan; Michael A Pulsipher; Mort J Cowan
Journal:  Biol Blood Marrow Transplant       Date:  2017-01-06       Impact factor: 5.742

6.  Insufficient immune reconstitution after allogeneic cord blood transplantation without chemotherapy conditioning in patients with SCID caused by CD3δ deficiency.

Authors:  H Takada; M Ishimura; T Hara
Journal:  Bone Marrow Transplant       Date:  2016-03-21       Impact factor: 5.483

Review 7.  Long term outcomes of severe combined immunodeficiency: therapy implications.

Authors:  Jennifer Heimall; Morton J Cowan
Journal:  Expert Rev Clin Immunol       Date:  2017-09-23       Impact factor: 4.473

8.  The long and the short of telomeres in bone marrow recipient SCID patients.

Authors:  Marcella Sarzotti-Kelsoe; Xiaoju G Daniell; John F Whitesides; Rebecca H Buckley
Journal:  Immunol Res       Date:  2011-04       Impact factor: 2.829

9.  Improving cellular therapy for primary immune deficiency diseases: recognition, diagnosis, and management.

Authors:  Linda M Griffith; Morton J Cowan; Luigi D Notarangelo; Jennifer M Puck; Rebecca H Buckley; Fabio Candotti; Mary Ellen Conley; Thomas A Fleisher; H Bobby Gaspar; Donald B Kohn; Hans D Ochs; Richard J O'Reilly; J Douglas Rizzo; Chaim M Roifman; Trudy N Small; William T Shearer
Journal:  J Allergy Clin Immunol       Date:  2009-12       Impact factor: 10.793

Review 10.  Clinical and imaging considerations in primary immunodeficiency disorders: an update.

Authors:  Eveline Y Wu; Lauren Ehrlich; Brian Handly; Donald P Frush; Rebecca H Buckley
Journal:  Pediatr Radiol       Date:  2016-09-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.